Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D005337:Fibrin / Q000032:analysis; D005455:Fluorescent Antibody Technique; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012910:Snake Venoms / Q000627:therapeutic use; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D012910:Snake Venoms; D014859:Warfarin; D004176:Dipyridamole; D003520:Cyclophosphamide; D005337:Fibrin; D006493:Heparin; D011239:Prednisolone; D001379:Azathioprine